Because they are both immune conditions, recent research has suggested a potential link between immune thrombocytopenic purpura and celiac disease. In a recent study, researchers assessed this association...
The US Food and Drug Administration has approved a new drug for the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
In a study of data from 2009 to 2013, researchers assessed incidence and complication rates, outcomes, and disease burden of heparin-induced thrombocytopenia in the United States.
In a study of data from 2009 to 2013, researchers assessed incidence and complication rates, outcomes, and disease burden of heparin-induced thrombocytopenia in the United States.
After reviewing data from 2 randomized placebo-controlled Phase 3 trials and an open-label extension, the FDA has approved a new option for the treatment of adults with chronic immune thrombocytopenia.
...
In a recent study, researchers sought to examine trends of splenectomy in hospitalizations with ITP, and the factors associated with splenectomy during these encounters.
In a recent study, researchers sought to examine trends of splenectomy in hospitalizations with ITP, and the factors associated with splenectomy during these encounters.
It is currently unclear how to best screen populations at risk for multiple myeloma and evaluate the potential effectiveness of early interventions. Using a computational model, researchers investigated...